CNBT
NVAX icon

Cornerstone National Bank & Trust’s Novavax NVAX Stock Holding History

Cornerstone National Bank & Trust’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-375
Closed -$3.02K – 175
2024
Q4 		$3.02K Hold
375
– – ﹤0.01% 158
2024
Q3 		$4.74K Buy
+375
New +$4.84K ﹤0.01% 155

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornerstone National Bank & Trust's NVAX Position: Q1 2025 in Review

Cornerstone National Bank & Trust sold out of Novavax (NVAX) in Q1 2025, closing a stake of 375 shares — an estimated $3.02K sold.

Cornerstone National Bank & Trust first reported a position in NVAX in Q3 2024 and held it in 2 quarters. The position peaked at $4.74K in Q3 2024. 245 funds tracked by Wall St. Rank hold NVAX as of Q1 2025.

  • Cornerstone National Bank & Trust reported no remaining Novavax position as of Q1 2025 after selling out during the quarter.
  • Cornerstone National Bank & Trust sold 375 Novavax shares in Q1 2025, an estimated $3.02K.
  • Cornerstone National Bank & Trust first reported a position in Novavax in Q3 2024 and held it in 2 quarters.
  • Cornerstone National Bank & Trust's Novavax position peaked at $4.74K in Q3 2024.
  • 245 funds tracked by Wall St. Rank held Novavax as of Q1 2025.

Based on Cornerstone National Bank & Trust's 13F filing for Q1 2025, filed 28 Jan 2026.